⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATAI News
Atai Beckley N.V Common Shares
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
globenewswire.com
ATAI
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
globenewswire.com
ATAI
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
globenewswire.com
ATAI
atai Life Sciences Announces Pricing of Public Offering of Common Shares
globenewswire.com
ATAI
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
globenewswire.com
ATAI
atai Life Sciences Announces Proposed Public Offering of Common Shares
globenewswire.com
ATAI